Japan: Govt Balancing Price Cuts, New Drug Support Amid MFN Concerns

 
• By Lisa Takagi
  
perspectives 2026
Japan 2026 ps
Pricing set to continue as a major industry concern in Japan in 2026 (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pink Sheet Perspectives

More from Japan